Novel pharmacological therapies for the treatment of endometriosis.

导出 LinkOut

翻译打印收藏纠错

作者： Laura,Buggio ^[1] ; Dhouha,Dridi ^[1] ; Giussy,Barbara ^[1] ; Camilla E M,Merli ^[2] ; Giulia Emily,Cetera ^[1] ; Paolo,Vercellini ^[1]

作者单位： Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. ^[1] Department of Clinical Sciences and Community Health, Università degli Studi, Milan, Italy. ^[2]

关键词 GnRH antagonist SERM SPRM elagolix endometriosis linzagolix relugolix

主题词子宫内膜异位症(Endometriosis);雌激素类(Estrogens);女(雌)性(Female);促性腺素释放激素(Gonadotropin-Releasing Hormone);激素拮抗药(Hormone Antagonists);人类(Humans);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone);选择性雌激素受体调节剂(Selective Estrogen Receptor Modulators)

DOI 10.1080/17512433.2022.2117155

PMID 36000243

发布时间 2022-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Expert review of clinical pharmacology

2022年15卷9期

1039-1052页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Novel pharmacological therapies for the treatment of endometriosis.

Expert review of clinical pharmacology

相似文献

Expert review of clinical pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Novel pharmacological therapies for the treatment of endometriosis.

Expert review of clinical pharmacology

相似文献

Expert review of clinical pharmacology

相关期刊

检索历史清除